FDA Inspection
Daniel A Long, MDDaniel A Long, MD – FDA Inspection, Oct 30, 2009
Record Details
This FDA Inspection record concerns Daniel A Long, MD, with an inspection on October 30, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Daniel A Long, MD
- Inspection Date
- October 30, 2009
- Product Type
- Drugs
View Company Profile
ID · c1880ad8-5fb9-43b7-a14d-acd5d5f24b03
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 625306
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Daniel A Long, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 3, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Daniel A Long, MD
- FDA Inspection 785278 - 2012-05-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.